Aplastic anemia in a patient with advanced lung adenocarcinoma during first line osimertinib: A case report and literature review
Luca Sala, Maddalena Mancin, Alessia Pastore, Davide Seminati, Diego Cortinovis, Paolo Bidoli, Andrea Alberti
Topics & Concepts
OsimertinibMedicineTolerabilityInternal medicineOncologyAdenocarcinomaAplastic anemiaEpidermal growth factor receptorLungBone marrowAdverse effectCancerErlotinibLung Cancer Treatments and MutationsPI3K/AKT/mTOR signaling in cancerGastric Cancer Management and Outcomes